Mimetis Biomaterials Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
- Investors
-
1
Mimetis Biomaterials General Information
Description
Designer and manufacturer of bone regenerative medical products intended for printing patient-specific biomimetic synthetic bone grafts in 3D and regenerating it physiologically. The company's product uses biomimicry as a differential technological basis and synthetically manufactures a bone graft for patient-specific indications that matches the features of a natural bone to provide solutions for complex cases, thereby enabling clients to facilitate the colonization of the graft by bone cells and avoid stacking over time.
Contact Information
Website
www.mimetis.com
Formerly Known As
Subtilis Biomaterials
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Parent Company
Primary Office
- Carrer de Cartagena, 245
- 3 Floor
- 08025 Barcelona
- Spain
+34 644 00 00 00
Mimetis Biomaterials Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 01-Sep-2022 | 00.000 | Completed | Clinical Trials - Phase 2 | ||
| 12. Later Stage VC (Series A) | 19-May-2021 | 00000 | 00.000 | 00.000 | Completed | Clinical Trials - Phase 2 |
| 11. Grant | 00.00 | 00.000 | Completed | Clinical Trials - Phase 2 | ||
| 10. Secondary Transaction - Private | 30-Sep-2019 | 00.000 | Completed | Clinical Trials - Phase 2 | ||
| 9. Grant | 01-Jan-2019 | 00000 | 00.000 | Completed | Clinical Trials - Phase 2 | |
| 8. Equity Crowdfunding | 14-Nov-2018 | 00000 | 00.000 | Completed | Clinical Trials - Phase 2 | |
| 7. Grant | 01-Jan-2018 | 00000 | 00.000 | Completed | Startup | |
| 6. Grant | 01-Jan-2016 | 000.00 | 00.000 | Completed | Startup | |
| 5. Grant | $201K | $1.15M | Completed | Startup | ||
| 4. Early Stage VC | 01-Jan-2016 | $762K | $1.15M | 00.000 | Completed | Startup |
Mimetis Biomaterials Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | ||
| Ordinary | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Ordinary | 4,978 | $68.02 | $68.02 | 1x | $68.02 | 15.34% |
Mimetis Biomaterials Patents
Mimetis Biomaterials Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3563881-A1 | Synthetic bone graft | Inactive | 03-May-2018 | 000000000 | 0 |
| EP-3787700-A1 | Synthetic bone graft | Pending | 03-May-2018 | 000000000 |
Mimetis Biomaterials Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ana Espinoza | Chief Executive Officer and Commercial Director | ||
| Maria-Pau Ginebra Ph.D | Co-Founder & President | ||
| Xavier Gil Ph.D | Co-Founder |
Mimetis Biomaterials Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Mimetis Biomaterials Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Barcelona Activa | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Biocat | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Caixa Capital Risc | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Centro para el Desarrollo Tecnológico Industrial | Government | 000 0000 | 000000 0 | ||
| European Commission | Government | 000 0000 | 000000 0 |